Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients

Clinical Cancer Research

Volumn 7, Issue 6, 2001, Pages 1739-1742

  Chang, Jenny ^a,b   Hilsenbeck, Susan G ^a,b   Sng, Jen Hwei ^a,b   Wong, John ^a,b   Ragu, G C ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA; ESTROGEN RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; FAMILY HISTORY; GENE MUTATION; GENETIC RISK; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONSET AGE; PREMENOPAUSE; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ADULT; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENETIC SCREENING; HUMANS; MUTATION; PREMENOPAUSE; RECEPTORS, ESTROGEN; RISK FACTORS;

EID: 0034901955     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
2. Identification of the breast cancer susceptibility gene BRCA2
3. NCCN Practice Guidelines. Genetics/familial high-risk cancer screening
4. Epidemiology of breast cancer
5. A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database
6. Estimates of the gene frequency of BRCA1 and its contribution to cancer incidence
7. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study
8. Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage
9. Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women
10. Steroid receptors in hereditary breast carcinomas associated with BRCA-1 or BRCA-2 mutations or unknown susceptibility genes
11. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations
12. Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer
13. Prevalence of BRCAI mutations in Chinese women with early-onset and familial breast cancer
14. Human, canine and murine BRCA1 genes: Sequence comparison among species
15. Rapid detection of BRCA1 mutations by the protein truncation test
16. Detection of BRCA1 mutations by the protein truncation test
17. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene
18. Murine Brca1: Sequence and significance for human missense mutations
19. Linkage of early-onset familial breast cancer to chromosome 17q2l
20. Effect of BRCAI and BRCA2 on the association between breast cancer risk and family history
21. BRCA1 mutations in a population-based sample of young women with breast cancer
22. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women
23. BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer
24. BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: Implications for breast-conserving management in patients with BRCA1/BRCA2 mutations
25. No deleterious effects of radiotherapy in women who are heterozygote for a BRCA-1 or BRCA-2 mutation following breast-conserving therapy
26. Breast cancer risk after bilateral prophylactic oophorectomy in BRCAI mutation carriers
27. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors
28. Tamoxifen and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: A case-control study